Clinical Question What is the ris...

Clinical Question

What is the risk of rebleeding or death in a patient with upper gastrointestinal (GI) bleeding?

Evidence Summary

Upper GI bleeding remains a belonging to all problem and reason for hospital admission. (1) A more precise estimate of a patient's prognosis would be helpful to physicians who are deciding in succession hospital discharge and the intensiveness of monitoring in inpatient and outpatient settings.

A clinical decision mastership has been developed that estimates the likelihood of mortality in patients presenting with upper GI bleeding. A meditation (2) by Rockall and colleagues identified all patients presenting to hospitals in four health regions with acute upper GI hemorrhage who subsequently underwent endoscopy. Patients whose bleeding occurr in the hospital and those who did not endure endoscopy were excluded from the close attention Patients were followed prospectively and their risk of rebleeding and death was determined. This clinical decision command has been validated (3-6) for the prediction of mortality. The largest and best designed of these validations (3) was a prospective evaluation in 951 Dutch patients with a median age of 71 years. Although near of these studies, (2,3,6) did not find that the prediction of rebleeding was as accurate as the prediction of death, the conduct does accurately identify a collection with a very low risk of rebleeding (Rockall score of 2 or lower). While other dominions (7-9) have been developed, they have not been as well validated as the Rockall (2) risk score.

The Rockall risk score and its interpretation using combined data from the original inquiry (2) and the Dutch validation application of mind (3) are shown in Figures 1 by the agency of 3. To use the clinical decision control determine the number of points for your patient using Figure 1 then determine the patient's risk of rebleeding and death using Figure 2 Data in Figure 2 are shown for individual scores, as well as scores grouping patients into low- moderate-, and high-risk collections A clinical score using the three nonendoscopic variables is shown in Figure 3; it may be especially helpful to family physicians, unless it has not been validated outside of Rockall's original validation reflection (2)

[FIGURES 1-3 OMITTED]

Obviously, no clinical decision command should be applied without the usual application of clinical decree However, these rules can help support clinical decision making on identifying patients who can be considered for early discharge and patients who are at an increased risk if it be not that might otherwise be considered for discharge from the hospital.

Applying the Evidence

Mr Sailors, a 43-year-old man who is in otherwise virtuous health, presents to the necessity department with a single episode of coffee-ground emesis and a large melanotic stool that morning. He has a six-month history of taking a nonsteroidal anti-inflammatory put drugs into for tendonitis. His blood hurry is 108/60 mm Hg, his heart rate is 108 beats by means of minute, and he complains of lightheadedness when he sits up in succession the gurney. After being stabilized, he undergoe endoscopy that reveals a small duodenal imposthume an adherent clot, and a certain old blood in the gastrointestinal tract. What is the likelihood that he will reble or die?

Answer: This patient realizes zero points for age, common point for shock, zero points for comorbidity, united point for diagnosis based forward endoscopy, and two points for stigmata of modern hemorrhage. His total risk score is four points, which bring forwards him in the moderate risk category (a 13 percent risk of rebleeding and a 68 percent risk of death). Based upon this information, the physician decides to mention him closely in an inpatient setting for an additional day or sum of two units rather than send him family circle right after the endoscopy.

REFERENCES

(1) Rockall TA, Logan RF Devlin HB Northfield TC Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ 1995;311:222-6

(2) Rockall TA, Logan RF Devlin HB Northfield TC Risk assessment after acute upper gastrointestinal haemorrhage. intestine 1996;38:316-21.

(3.) Vreeburg EM Terwee CB Snel P Rauws EA, Bartelsman JF Meulen JH et al. Validation of the Rockall risk scoring scheme in upper gastrointestinal bleeding. take out the bowels of 1999;44:331-5.

(4.) Sanders D Carter MJ Goodchap RJ Cros S Gleeson DC Lobo AJ. Prospective validation of the Rockall risk scoring connected view for upper GI hemorrhage in subgroup of patients with varices and peptic sore s Am J Gastroenterol 2002;97:630-5.

(5) Oei TT Dulai G Gralnek IM, Chang D Kilbourne AM, Sale GA. Hospital care for low-risk patients with acute, nonvariceal upper GI hemorrhage: a comparison of neighboring community and tertiary care center Am J Gastroenterol 2002;97:2271-8

(6) Camellini L Merighi A, Pagnini C Azzolini F Guazzetti s Scarcelli A, et al. Comparison of three different risk scoring arrangements in non-variceal upper gastrointestinal bleeding. Dig Liver Dis 2004;36:271-7